Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

TILADE

NEDOCROMIL SODIUM

Standard Dose
1.75MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TILADE is listed in Drugs@FDA under application 019660 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient NEDOCROMIL SODIUM Form and strength AEROSOL, METERED;INHALATION - 1.75MG/INH Sponsor KING PHARMS LLC Submission history Latest submission status date: 2004-02-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview TILADE is listed in Drugs@FDA under application 019660 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NEDOCROMIL SODIUM Form and strength AEROSOL, METERED;INHALATION - 1.75MG/INH Sponsor KING PHARMS LLC Submission history Latest submission status date: 2004-02-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.